Remote Exercise for Learning Anger and Excitation Management
| Status: | Completed |
|---|---|
| Conditions: | Psychiatric, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/7/2015 |
| Start Date: | March 2014 |
| End Date: | November 2015 |
Remote Exercise for Learning Anger and Excitation Management (RELAX)
The immediate objective of this project is to demonstrate the feasibility of Remote
Exercises for Learning Anger and Excitation Management (RELAX). The application is a remote,
technology- enabled, anger treatment and management system based on current evidence-based
CBT interventions. The project's objective is to show that RELAX (1) enables the practice of
anger management strategies remotely through mobile phone interfaces; (2) integrates with
evidence-based treatments through the implementation of an existing CBT anger management
course; (3) provides information, direction, and feedback through physiological sensors and
signal analysis; and (4) supports communication and direction by the therapist through a
web-based therapist interface.
Exercises for Learning Anger and Excitation Management (RELAX). The application is a remote,
technology- enabled, anger treatment and management system based on current evidence-based
CBT interventions. The project's objective is to show that RELAX (1) enables the practice of
anger management strategies remotely through mobile phone interfaces; (2) integrates with
evidence-based treatments through the implementation of an existing CBT anger management
course; (3) provides information, direction, and feedback through physiological sensors and
signal analysis; and (4) supports communication and direction by the therapist through a
web-based therapist interface.
This project will conduct a cognitive behavioral therapy (CBT) anger management treatment
groups with a Veteran population using the RELAX application, collect weekly feedback from
participants, and collaborate with the Sponsor to document initial efficacy, feasibility,
and safety of the RELAX system. Outcome domains include: 1) clinical outcomes (symptom
severity, social functioning); 2) process outcomes (perception of treatment, satisfaction,
group therapy alliance, treatment compliance, and attrition and treatment credibility); and
(3) Technical feasibility of the RELAX application. Study clinicians will be 1) trained to
conduct baseline and follow-up assessments 2) trained to conduct the standardized Anger
Management Therapy (AMT) protocol at acceptable levels of adherence and competence and 3)
trained how to use the technology and how to respond to technical difficulties. Study
clinicians will test the feasibility of the RELAX application and show that it can be
integrated with CBT anger management therapies and support therapist communication through
the technology.
groups with a Veteran population using the RELAX application, collect weekly feedback from
participants, and collaborate with the Sponsor to document initial efficacy, feasibility,
and safety of the RELAX system. Outcome domains include: 1) clinical outcomes (symptom
severity, social functioning); 2) process outcomes (perception of treatment, satisfaction,
group therapy alliance, treatment compliance, and attrition and treatment credibility); and
(3) Technical feasibility of the RELAX application. Study clinicians will be 1) trained to
conduct baseline and follow-up assessments 2) trained to conduct the standardized Anger
Management Therapy (AMT) protocol at acceptable levels of adherence and competence and 3)
trained how to use the technology and how to respond to technical difficulties. Study
clinicians will test the feasibility of the RELAX application and show that it can be
integrated with CBT anger management therapies and support therapist communication through
the technology.
Inclusion Criteria:
- a score of 20 or higher on the 10-item Trait Scale of the STAXI
- participants taking psychoactive medications have to have a stable regimen for at
least 45 days prior to study entry
- participants must be able to read, understand, and sign the consents themselves and
be willing and able to comply with all study related procedures
Exclusion Criteria:
- active psychotic symptoms/disorder as determined by the Structured Clinical Interview
(SCID) for Diagnostic and Statistical Manual of Mental Disorders(DSM)
- active homicidal or suicidal ideation as determined by the SCID
- any significant cognitive impairment or history of Organic Mental Disorder as
determined by the SCID
- active (current) substance dependence as determined by the SCID (lifetime substance
dependence or substance abuse not excluded), AUDIT, and the DAST
- unwillingness to refrain from substance abuse during treatment
- female Veterans
- vulnerable persons such as those described in the section Ethical Considerations and
Regulatory Issues, Vulnerable Population
We found this trial at
1
site
Click here to add this to my saved trials
